(Q40622261)

22 September 2017

1 reference

title

Lyme borreliosis: basic science and clinical aspects (English)

1 reference

22 September 2017

0 references

H W Pfister

1

1 reference

22 September 2017

B Wilske

series ordinal

2

1 reference

22 September 2017

K Weber

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

343

1 reference

22 September 2017

issue

8904

1 reference

22 September 2017

page(s)

1013-1016

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

22 September 2017

1 reference

7 January 2021

Lyme disease-a tick-borne spirochetosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Active immunization with pC protein ofBorrelia burgdorferi protects gerbils againstB. burgdorferi infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Borrelia burgdorferi--specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Laboratory considerations in the diagnosis and management of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990130-9

7 January 2021

10.1016/S0140-6736(94)90130-9

Identifiers

DOI

1 reference

22 September 2017

1 reference